Stay updated on Medicenna Therapeutics Press Releases
Sign up to get notified when there's something new on the Medicenna Therapeutics Press Releases page.

Latest updates to the Medicenna Therapeutics Press Releases page
- ChecktodayChange DetectedThe news-release list now includes Medicenna’s second-quarter fiscal 2027 financial results and an update on Bizaxofusp survival outcomes in glioblastoma. Older releases about the ABILITY-1 presentation and the shareholder meeting are no longer listed.SummaryDifference3%

- Check7 days agoChange DetectedMedicenna’s news list adds a November 9, 2026 release presenting ABILITY-1 results at SITC 2026, reporting a 40% ORR in biomarker-enriched gastrointestinal cancer patients resistant to approved therapies. The September 24 announcement about presenting bizaxofusp results at a neuro-oncology meeting is no longer listed.SummaryDifference3%

- Check14 days agoChange DetectedMedicenna’s news releases now include a November 4, 2026 announcement of ABILITY-1 enrollment completion and a webinar on updated MDNA11 results. The September 3, 2026 announcement about a conference appearance is no longer listed.SummaryDifference4%

- Check21 days agoChange DetectedMedicenna’s news-release list now features an October 26, 2026 announcement reporting CD122 blockade and extended survival with MDNA209 in preclinical autoimmune disease models. The August 14, 2026 release on first-quarter fiscal 2027 financial results and upcoming conference presentations is no longer listed.SummaryDifference3%

- Check28 days agoChange DetectedA new October 22, 2026 news release announces Medicenna’s planned presentation of preclinical data on its CD122 superantagonist MDNA209. The June 26, 2026 fiscal-year results and operational-highlights release is no longer listed.SummaryDifference3%

- Check42 days agoChange DetectedThe news releases list now features Medicenna’s October 5, 2026 announcement of an oral presentation of topline ABILITY-1 study data at SITC 2026. The June 11, 2026 release about newly issued and allowed patents has been removed from the displayed list.SummaryDifference3%

Stay in the know with updates to Medicenna Therapeutics Press Releases
Enter your email address, and we'll notify you when there's something new on the Medicenna Therapeutics Press Releases page.